Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug Trials.

Published

Journal Article

Good Participatory Practice Guidelines for TB Drug Trials (GPP-TB) were issued in 2012, based on similar guidelines for HIV prevention and reflecting growing acceptance of the importance of community engagement and participatory strategies in clinical research. Though the need for such strategies is clear, evaluation of the benefits and burdens are needed. Working with a diverse group of global TB stakeholders including advocates, scientists, and ethicists, we used a Theory of Change approach to develop an evaluation framework for GPP-TB that includes a clearly defined ethical goal, a set of powerful strategies derived from GPP-TB practices for achieving the goal, and outcomes connecting strategies to goal. The framework is a first step in systematically evaluating participatory research in clinical trials.

Full Text

Duke Authors

Cited Authors

  • MacQueen, KM; Eley, NT; Frick, M; Mingote, LR; Chou, A; Seidel, SS; Hannah, S; Hamilton, C

Published Date

  • July 2016

Published In

Volume / Issue

  • 11 / 3

Start / End Page

  • 203 - 213

PubMed ID

  • 27368311

Pubmed Central ID

  • 27368311

Electronic International Standard Serial Number (EISSN)

  • 1556-2654

Digital Object Identifier (DOI)

  • 10.1177/1556264616657452

Language

  • eng

Conference Location

  • United States